uric acid has been researched along with tiletamine hydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Einhorn, R; Franki, N; Hays, RM; Levine, SD | 1 |
| Kettle, AJ; Winterbourn, CC | 1 |
| Bentkowski, Z; Holme, E; Lindstedt, S; Pronicka, E; Rowinska, E; Zawadzki, J | 1 |
3 other study(ies) available for uric acid and tiletamine hydrochloride
| Article | Year |
|---|---|
Vasopressin-stimulated movement of drugs and uric acid across the toad urinary bladder.
Topics: Adenine; Animals; Anti-Bacterial Agents; Anura; Butanols; Cell Membrane Permeability; Cyclic AMP; Cyclohexanones; Female; Fluorouracil; Glutethimide; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Phloretin; Stimulation, Chemical; Uric Acid; Urinary Bladder; Vasopressins | 1976 |
Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid.
Topics: Cyclohexanones; Cytochrome c Group; Humans; Hydrogen Peroxide; Hypochlorous Acid; Peroxidase; Spectrophotometry; Superoxide Dismutase; Superoxides; Uric Acid; Xanthine Oxidase | 1988 |
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Child; Cyclohexanones; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Nitrobenzoates; Osteoporosis; Phosphates; Reference Values; Tyrosine; Uric Acid | 1996 |